ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Authors

  • Maheshwari P Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11s4.31734

Keywords:

Chronic kidney disease, Cognitive assessment, Post-dialysis, Pre-dialysis

Abstract

Objectives: The objectives of this study were to evaluate cognitive profile in patients with chronic kidney disease (CKD) pre-dialysis and post-dialysis, to assess the severity of cognitive impairment in patients with kidney disease before and after dialysis, and to determine the association of cognitive impairment in relation to dialysis.

Methods: A total of 59 patients were recruited with CKD Stage V on dialysis for >6 months. Cognitive function of the patient was assessed by Montreal Cognitive Assessment test scale method for three intervals (before dialysis and two intervals post-dialysis), and the incidence of impairment was analyzed using one-way ANOVA variance test.

Results: Among the 59 patients, there were 13 patients with the age of 18–33 years (22.033%), 11 patients with from age 34 to 49 years (18.64%), 21 patients at the age of 50–65 years (35.59%), and 15 patients around 66–80 years (25.42%). From the above categories, population with the age of 50–65 years is at maximum affected by CKD. Among the 59 patients, 24 patients (40.677%) are male and 35 patients (59.33%) are female. There was a mild significant difference seen in cognitive functioning between pre-dialysis and post-dialysis (p≤0.02).

Conclusion: It was found that patients with CKD had mild-to-moderate cognitive dysfunction due to morbidities associated with CKD. In

this study, significant differences of cognitive function result in CKD patients and the severity of cognitive impairment was associated

with the severity of the kidney disease, which improved with dialysis. Finally, our study suggests that cognitive performance was

improved after initiation of dialysis and that further management through medications could provide a better outcome in cognitive

performance.

Downloads

Download data is not yet available.

References

Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, et al. Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 2005;16:2127-33.

Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, et al. Cognitive impairment in hemodialysis patients is common. Neurology 2006;67:216-23.

Nasser Mel T, Shawki S, El Shahawy Y, Sany D. Assessment of cognitive dysfunction in kidney disease. Saudi J Kidney Dis Transpl 2012;23:1208-14.

Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76-80.

Williams MA, Sklar AH, Burright RG, Donovick PJ. Temporal effects of dialysis on cognitive functioning in patients with ESRD. Am J Kidney Dis 2004;43:705-11.

Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol 2009;5:542-51.

Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B, et al. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 1990;38:480-6.

Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: Diagnostic and therapeutic strategies. Kidney Int 2011;79:14-22.

Weiner DE, Seliger SL. Cognitive and physical function in chronic kidney disease. Curr Opin Nephrol Hypertens 2014;23:291-7.

Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA, et al. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 2009;73:920-7.

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006;17:2034-47.

Published

28-12-2018

How to Cite

P, M. “ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 16, Dec. 2018, pp. 193-4, doi:10.22159/ajpcr.2018.v11s4.31734.

Issue

Section

Original Article(s)